8-104348883-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030788.4(DCSTAMP):c.331G>A(p.Val111Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030788.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCSTAMP | NM_030788.4 | c.331G>A | p.Val111Ile | missense_variant | 2/4 | ENST00000297581.2 | NP_110415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCSTAMP | ENST00000297581.2 | c.331G>A | p.Val111Ile | missense_variant | 2/4 | 1 | NM_030788.4 | ENSP00000297581 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251344Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135832
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461880Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727242
GnomAD4 genome AF: 0.000164 AC: 25AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.331G>A (p.V111I) alteration is located in exon 2 (coding exon 1) of the DCSTAMP gene. This alteration results from a G to A substitution at nucleotide position 331, causing the valine (V) at amino acid position 111 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at